Decipher how mRNAs are captured at specific subcellular locations to support local translation in neurons

RNA.ORG aims to uncover the molecular mechanisms of mRNA localization and translation in neurons to understand their role in neuronal function and dysregulation in ALS.

Subsidie
€ 1.499.140
2025

Projectdetails

Introduction

Brain function requires precise regulation of the neuronal proteome, which involves localizing thousands of mRNAs to neurites, where specific subsets are translated at the required subcellular locations. Although local translation is well-established, the mechanisms that ensure the capture and translation of specific mRNAs at the correct subcellular location remain elusive. A better understanding of this process is urgent since dysregulation of mRNA localization and translation is emerging as a key pathological event in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).

Project Aim

In RNA.ORG, I aim to define, at a molecular level, how the coordination between mRNA transport, capture, and local translation occurs to support neuronal function.

Background

Recent work from my lab and others has shown that multiple organelles interact with mRNA and translational machinery. This raises the exciting possibility that organelle interactions coordinate mRNA distribution, local capture, and selective translation. I have developed tools to visualize and manipulate organelle position and contacts at nanoscale resolution. Here, I will leverage these tools and directly control mRNA positioning to elucidate the importance of mRNA capture in neuronal function and intervene in its dysregulation in ALS.

Key Objectives

In combination with live-cell and super-resolution imaging, RNA-sequencing, and proteomics, this project will address the following key objectives:

  1. Resolve the subcellular distribution and dynamics of neuronal organelle-mRNA contacts.
  2. Unravel the functions of organelle-mediated mRNA capture at specific subcellular locations.
  3. Determine the role of dysregulated mRNA capture in amyotrophic lateral sclerosis.

Expected Outcomes

RNA.ORG will elucidate novel mechanisms on the subcellular capture and translation of specific mRNAs in neurons and will provide new insights into the role of local mRNA positioning in neuronal development, physiology, and pathology.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.140
Totale projectbegroting€ 1.499.140

Tijdlijn

Startdatum1-1-2025
Einddatum31-12-2029
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • STICHTING VUpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Starting...

3-dimensional Organization and Functions of Translation in Organelle Proximity

This project aims to uncover the mechanisms linking translation regulation and organelle biogenesis using functional genomics and cryo-ET to map and understand proximal translation in eukaryotic cells.

€ 1.999.838
ERC Consolid...

Translational Control of Neuronal Fate and Identity

This project aims to investigate how translational control via mature tRNA availability regulates gene expression and neuronal diversity during cortical development in mice.

€ 2.000.000
ERC Starting...

Mechanisms of human co-translational quality control and it’s role in neural tissue.

This project aims to elucidate the mechanisms of ribosome-associated quality control in humans and its implications for neurodegeneration and aging, using cryo-EM and C. elegans models.

€ 1.500.000
ERC Advanced...

Understanding the molecular principles governing mRNP architecture

The GOVERNA project aims to elucidate the structure and function of eukaryotic mRNPs by purifying and analyzing their composition using advanced biochemical and imaging techniques.

€ 2.171.250
ERC Starting...

Deciphering co-translational protein folding, assembly and quality control pathways, in health and disease

This project aims to elucidate co-translational protein folding and degradation mechanisms to understand misfolding diseases and improve therapeutic strategies.

€ 1.412.500